Cardiac troponin monitoring for detection of myocardial infarction: Newer generation assays are here to stay

Clinica Chimica Acta

Volumn 380, Issue 1-2, 2007, Pages 1-3

  Apple, Fred S ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; MYOGLOBIN; TROPONIN; TROPONIN I; TROPONIN T;

CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EDITORIAL; ELECTROCARDIOGRAPHY; HEART INFARCTION; HEART MOVEMENT; HUMAN; PRIORITY JOURNAL; Q WAVE; SENSITIVITY ANALYSIS;

BIOLOGICAL MARKERS; CREATINE KINASE, MB FORM; HUMANS; MYOCARDIAL INFARCTION; MYOGLOBIN; TROPONIN I;

EID: 33947662426     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.01.002     Document Type: Editorial

References (25)

1. Jaffe A.S., Ravkilde J., Roberts R., et al. It's time for a change to a troponin standard. Circulation 102 (2000) 1216-1220
2. Alpert J.S., Thygesen K., and for the Cardiology Committee for the Redefinition of Myocardial Infarction. Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 21 (2000) 1502-1513
3. Thygesen K, Alpert JS, White HD, on behalf of the Joint ESC-ACC-AHA-WHF Task Force for the redefinition of myocardial infarction. Myocardial infarction redefined - a consensus document revised. Manuscript in preparation.
4. Jaffe A.S., Babuin L., and Apple F.S. Biomarkers in acute coronary disease: the present and the future. J Am Coll Cardiol 48 (2006) 1-11
5. Apple F.S., Quist H.E., Doyle P.J., Otto A.P., and Murakami M.M. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem 49 (2003) 1331-1336
6. Apple FS, Jesse RL, Newby LK, Wu AHB, Christenson RH. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: analytical issues for biomarkers of acute coronary syndromes. Clin Chem, accepted for publication.
7. Venge P., et al., on behalf of the FRISC II Study Group. Clinical performance of three cardiac troponin assays in patients with unstable coronary artery disease (a FRISC II Substudy). Am J Cardiol 89 (2002) 1035-1041
8. Morrow DA, Christenson RH, for the National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines Committee. Characterization and utilization of biomarkers in acute coronary syndrome. Circulation and Clin Chem jointly accepted for publication.
9. Kavsak P.A., MacRae A.R., Newman A.M., et al. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarctions. Clin Chim Acta 380 (2007) 213-216
10. Zimmerman J., Fromm R., Meyer D., et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 99 (1999) 1671-1677
11. Lin J.C., Apple F.S., Murakami M.M., and Luepker R.V. Rates of positive cardiac troponin I and creatine kinase MB among patients hospitalized for suspected acute coronary syndromes. Clin Chem 50 (2004) 333-338
12. Eggers K.M., Oldgren J., Nordenskjold A., and Lindahl B. Diagnostic value of serial measurements of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 148 (2004) 574-581
13. Mockel M., Gerhardt W., Heller G., et al. Validation of NASCB and IFCC guidelines for the use of cardiac markers for early diagnosis and risk assessment in patients with acute coronary syndromes. Clin Chim Acta 303 (2001) 167-179
14. Newby L.K., Christenson R.H., Ohman E.M., et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. Circulation 98 (1998) 1853-1859
15. deWinter R.J., Koster R.W., Schotveld J.H., Sturk A., and Sanders G.T. Prognostic value of troponin T, myoglobin, and CK-MB in patients presenting with chest pain without acute myocardial infarction. Heart 75 (1996) 235-239
16. Morrow D.A., Cannon C.P., Rifai N., et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST-elevation myocardial infarction: results from a randomized trial. JAMA 286 (2001) 2405-2412
17. Newby L.K., Kaplan A.L., Granger B.B., Sedor F., Califf R.M., and Ohman E.M. Comparison of cardiac troponin T versus creatine kinase-MB for risk stratification in a chest pain evaluation unit. Am J Cardiol 85 (2000) 801-805
18. Newby L.K., Storrow A.B., Gibler B., et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation of creatine kinase-MB, myoglobin and troponin I (CHECKMATE) study. Circulation 103 (2001) 1832-1837
19. Mockel M., Stork T., Heller G., et al. Troponin T in patients with low grade or atypical angina: identification of a high risk group for short and long term cardiovascular events. Eur Heart J 19 (1998) 1802-1807
20. Morrow D.A., Rifai N., Tanasijevic M.J., Wybenga D.R., DeLemos J.A., and Antman E.M. Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a thrombolysis in myocardial infarction (TIMI) IIB substudy. Clin Chem 46 (2000) 453-460
21. Kavsak P.A., MacRae A.R., Lustig V., et al. The impact of the ESWC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarction. Am Heart J 152 (2006) 118-125
22. MacRae A.R., Kavsak P.A.S., Lustig V., et al. Assessing the requirement for the six hour interval between specimens in the American Heart Association classification of myocardial infarction in epidemiology and clinical research studies. Clin Chem 52 (2006) 812-818
23. Fesmire F.M., Christenson R.H., Fody E.P., and Feintuch T.A. Delta creatine kinase-MB outperforms myoglobin at two hours during the emergency department identification and exclusion of troponin positive non-ST-elevation acute coronary syndromes. Ann Emerg Med 44 (2004) 12-19
24. Apple F.S., Johari V., Hoybook K.J., Weber-Shrikant E., Davis G.K., and Murakami M.M. Operationalizing cardiac troponin I testing along ESC/ACC consensus guidelines for defining myocardial infarction. Clin Chim Acta 331 (2003) 165-166
25. Luepker R.V., Apple F.S., Christenson R.H., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies. Circulation 108 (2003) 2543-2549